Literature DB >> 8764716

Controlled clinical study of skin donor sites and deep partial-thickness burns treated with cultured epidermal allografts.

M T Rivas-Torres1, D Amato, H Arámbula-Alvarez, W Kuri-Harcuch.   

Abstract

Two clinical studies in donor sites and deep partial-thickness burns treated with banked cultured human epidermal allografts are described. Ten burn patients were subjected to donor split-thickness skin harvesting. The study was controlled, side-by-side comparative, blind, and randomized. Banked cultured epidermal allografts promoted a faster reepithelialization of the wounds; they epithelialized in an average of 6.9 days, whereas controls healed in an average of 11.1 days, giving a reduction of 37.8 percent in time to heal (p < 0.005). Allografted sites were less erythematous as compared with controls (p < 0.01), with more tendency to normopigmentation. In the deep partial-thickness burns study, 10 patients with 18 burned wounds were treated. Wounds treated with cultured allografts showed complete reepithelialization in about 3 to 6 days. The two clinical studies showed that banked cultured epidermal allograft promotes a significantly faster epithelialization of donor sites and deep partial-thickness wounds. These results support the idea that cultured allografts should be used routinely to improve treatment of burn patients and reduce their therapy time.

Entities:  

Mesh:

Year:  1996        PMID: 8764716     DOI: 10.1097/00006534-199608000-00011

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  8 in total

1.  Establishment of a keratinocyte and fibroblast bank for clinical applications in Japan.

Authors:  Takashi Nakano; Yasuhiro Katayama; Michiharu Sakamoto; Yoshihiro Shimizu; Masukazu Inoie; Norio Shimizu; Hiroki Yamanaka; Itaru Tsuge; Susumu Saito; Naoki Morimoto
Journal:  J Artif Organs       Date:  2022-05-05       Impact factor: 1.731

2.  Epidermal keratinocytes do not activate peripheral T-cells: interleukin-10 as a possible regulator.

Authors:  Rocío Isabel Domínguez-Castillo; Erika Sánchez-Guzmán; Federico Castro-Muñozledo; Leopoldo Santos-Argumedo; Walid Kuri-Harcuch
Journal:  Immunology       Date:  2008-05-20       Impact factor: 7.397

Review 3.  Cell therapy in dermatology.

Authors:  Gabriela Petrof; Alya Abdul-Wahab; John A McGrath
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

4.  Feeder layer- and animal product-free culture of neonatal foreskin keratinocytes: improved performance, usability, quality and safety.

Authors:  Peter De Corte; Gunther Verween; Gilbert Verbeken; Thomas Rose; Serge Jennes; Arlette De Coninck; Diane Roseeuw; Alain Vanderkelen; Eric Kets; David Haddow; Jean-Paul Pirnay
Journal:  Cell Tissue Bank       Date:  2011-03-11       Impact factor: 1.522

5.  Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies.

Authors:  John S Graham; Robert P Chilcott; Paul Rice; Stephen M Milner; Charles G Hurst; Beverly I Maliner
Journal:  J Burns Wounds       Date:  2005-01-05

6.  Improved wound healing of cutaneous sulfur mustard injuries in a weanling pig model.

Authors:  John S Graham; Robert S Stevenson; Larry W Mitcheltree; Marcia Simon; Tracey A Hamilton; Robin R Deckert; Robyn B Lee
Journal:  J Burns Wounds       Date:  2006-11-08

7.  Cultured Human Epidermis Combined With Meshed Skin Autografts Accelerates Epithelialization and Granulation Tissue Formation in a Rat Model.

Authors:  Michiharu Sakamoto; Naoki Morimoto; Masukazu Inoie; Miki Takahagi; Shuichi Ogino; Chizuru Jinno; Shigehiko Suzuki
Journal:  Ann Plast Surg       Date:  2017-06       Impact factor: 1.539

8.  Dried human cultured epidermis accelerates wound healing in diabetic mouse skin defect wounds.

Authors:  Michiharu Sakamoto; Takashi Nakano; Itaru Tsuge; Hiroki Yamanaka; Yasuhiro Katayama; Yoshihiro Shimizu; Yoshika Note; Masukazu Inoie; Naoki Morimoto
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.